The Nuclear Receptor ERRα Is Required for the Bioenergetic and Functional Adaptation to Cardiac Pressure Overload

Cell Metabolism

Volumn 6, Issue 1, 2007, Pages 25-37

  Huss, Janice M ^a   Imahashi, Ken ichi ^b   Dufour, Catherine R ^c   Weinheimer, Carla J ^a   Courtois, Michael ^a   Kovacs, Atilla ^a   Giguère, Vincent ^c   Murphy, Elizabeth ^b   Kelly, Daniel P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

DEVBIO; HUMDISEASE

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS RECEPTOR; CREATINE PHOSPHATE; ESTROGEN RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATE; BIOLOGICAL MARKER; ERRALPHA ESTROGEN RELATED RECEPTOR; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART PROTECTION; HEMODYNAMIC STRESS; HYPOTHESIS; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PATHOGENESIS; PHOSPHATE TRANSPORT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CARDIOMEGALY; CYTOLOGY; DNA MICROARRAY; ENERGY METABOLISM; FEMALE; FORWARD HEART FAILURE; GENE EXPRESSION PROFILING; GENETICS; HEART; HEART MUSCLE CELL; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CARDIOMEGALY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; HEART; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 34347248013     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.06.005     Document Type: Article

References (54)

1. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., Jonker J.W., Giles W., Naviaux R.K., Giguère V., and Evans R.M. ERRγ directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 6 (2007) 13-24 this issue
2. Allard M.F., Schonekess B.O., Henning S.L., English D.R., and Lopaschuk G.D. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am. J. Physiol. 267 (1994) H742-H750
3. Anversa P., Loud A.V., Giacomelli F., and Weiner J. Absolute morphometric study of myocardial hypertrophy in experimental hypertension. II. Ultrastructure of myocytes and interstitium. Lab. Invest. 38 (1978) 597-609
4. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., Ahmad F., Matsui T., Chin S., Wu P.-H., et al. Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metab. 1 (2005) 259-271
5. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., and Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPARγ coactivator 1α. Proc. Natl. Acad. Sci. USA 103 (2006) 10086-10091
6. Ashrafian H., Redwood C., Blair E., and Watkins H. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet. 19 (2003) 263-268
7. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., Kim I.F., Soboleva A., Tomashevsky M., and Edgar M. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res. 35 (2007) D760-D765
8. Bennett M.J., Rinaldo P., and Strauss A.W. Inborn errors of mitochondrial fatty acid oxidation. Crit. Rev. Clin. Lab. Sci. 37 (2000) 1-44
9. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., and Abel E.D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112 (2005) 2686-2695
10. Carrier J.C., Deblois G., Champigny C., Levy E., and Giguere V. Estrogen-related receptor α (ERRα) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem. 279 (2004) 52052-52058
11. Christe M.D., and Rodgers R.L. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J. Mol. Cell. Cardiol. 26 (1994) 1371-1375
12. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am. J. Physiol. 283 (2002) H481-H489
13. de las Fuentes L., Herrero P., Peterson L.R., Kelly D.P., Gropler R.J., and Davila-Roman V.G. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertension and in left ventricular dysfunction. Hypertension 41 (2003) 83-87
14. de Roos A., Doornbos J., Luyten P., Oosterwaal L., van der Wall E., and den Hollander J. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: Assessment with proton-decoupled P-31 MR spectroscopy. J. Magn. Reson. Imaging 2 (1992) 711-719
15. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., and Giguère V. Genome-wide orchestration of cardiac functions by orphan nuclear receptors ERRα and γ. Cell Metab. 5 (2007) 345-356
16. Finck B.N., and Kelly D.P. PGC-1 coactivators: Inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116 (2006) 615-622
17. Garnier A., Fortin D., Deloménie C., Momken I., Veksler V., and Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551 (2003) 491-501
18. Holmes B.F., Sparling D.P., Olson A.L., Winder W.W., and Dohm G.L. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am. J. Physiol. Endocrinol. Metab. 289 (2005) 1071-1076
19. Huss J.M., and Kelly D.P. Mitochondrial energy metabolism in heart failure: A question of balance. J. Clin. Invest. 115 (2005) 547-555
20. Huss J.M., Kopp R.P., and Kelly D.P. PGC-1α coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and -γ. J. Biol. Chem. 277 (2002) 40265-40274
21. Huss J.M., Pinéda Torra I., Staels B., Giguère V., and Kelly D.P. ERRα directs PPARα signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 24 (2004) 9079-9091
22. Iemitsu M., Miyazaki H., Matsuda M., and Yamaguchi I. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am. J. Physiol. 281 (2001) R2029-R2036
23. Imahashi K., Schneider M.D., Steenbergen C., and Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95 (2004) 734-741
24. Ingwall J.S., Kramer M.F., Fifer M.A., Lorell B.H., Shemin R., Grossman W., and Allen P.D. The creatine kinase system in normal and diseased human myocardium. N. Engl. J. Med. 313 (1985) 1050-1054
25. Ingwall J.S., and Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95 (2004) 135-145
26. Kayar S.R., and Weiss H.R. Diffusion distances, total capillary length, and mitochondrial volume in pressure overload myocardial hypertrophy. J. Mol. Cell. Cardiol. 24 (1992) 1155-1166
27. Kelly D.P., and Strauss A.W. Inherited cardiomyopathies. N. Engl. J. Med. 330 (1994) 913-919
28. Lehman J.J., and Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail. Rev. 7 (2002) 175-185
29. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., Courtois M., Wozniak D.F., Sambandam N., Bernal-Mizrachi C., et al. PGC-1α deficient mice exhibit multi-system energy metabolic derangements: Muscle dysfunction, abnormal weight control, and hepatic steatosis. PLoS Biol. 3 (2005) 672-687
30. Lin J., Handschin C., and Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1 (2005) 361-370
31. Luo J., Sladek R., Carrier J., Bader J.A., Richard D., and Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol. Cell. Biol. 23 (2003) 7947-7956
32. Maloyan A., Sanbe A., Osinska H., Westfall M., Robinson D., Imahashi K.-I., Murphy E., and Robbins J. Mitochondrial dysfunction and apoptosis underlie the pathogenic process in α-B-crystallin desmin-related cardiomyopathy. Circulation 112 (2005) 3451-3461
33. Mootha V.K., Handschin C., Arlow D., Xie X., St.Pierre J., Sihag S., Yang W., Altshuler D., Puigserver P., Patterson N., et al. ERRα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. USA 101 (2004) 6570-6575
34. Neubauer S. The failing heart-an engine out of fuel. N. Engl. J. Med. 356 (2007) 1140-1151
35. Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., Pabst T., Ertl G., Hahn D., Ingwall J.S., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 (1997) 2190-2196
36. Palmieri L., Alberio S., Pisano I., Lodi T., Meznaric-Petrusa M., Zidar J., Santoro A., Scarcia P., Fontanesi F., Lamantea E., et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum. Mol. Genet. 14 (2005) 3079-3088
37. Rockman H.A., Ross R.S., Harris A.N., Knowlton K.U., Steinhelper M.E., Field L.J., Ross Jr. J., and Chien K.R. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 88 (1991) 8277-8281
38. Sack M.N., Disch D.L., Rockman H.A., and Kelly D.P. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc. Natl. Acad. Sci. USA 94 (1997) 6438-6443
39. Saks V.A., Kuznetsov A.V., Vendelin M., Guerrero K., Kay L., and Seppet E.K. Functional coupling as a basic mechanism of feedback regulation of cardiac energy metabolism. Mol. Cell. Biochem. 256-257 (2004) 185-199
40. Saks V.A., Veksler V.I., Kuznetsov A.V., Kay L., Sikk P., Tiivel T., Tranqui L., Olivares J., Winkler K., Wiedemann F., et al. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol. Cell. Biochem. 184 (1998) 81-100
41. Sano M., Wang S.M., Shirai M., Scaglia F., Xie M., Sakai S., Tanaka T., Kulkarni P.A., Barger P.M., Youker K.A., et al. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J. 23 (2004) 3559-3569
42. Schreiber S.N., Emter R., Hock M.B., Knutti D., Cardenas J., Podvinec M., Oakeley E.J., and Kralli A. The estrogen-related receptor alpha (ERRα) functions in PPARγ coactivator 1α (PGC-1α) - induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 6472-6477
43. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., and Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα). J. Biol. Chem. 278 (2003) 9013-9018
44. Strøm C.C., Aplin M., Ploug T., Christoffersen T.E.H., Langfort J., Viese M., Galbo H., Haunso S., and Sheikh S.P. Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J. 272 (2005) 2684-2695
45. Taegtmeyer H., Razeghi P., and Young M.E. Mitochondrial proteins in hypertrophy and atrophy: A transcript analysis in rat heart. Clin. Exp. Pharmacol. Physiol. 29 (2002) 346-350
46. Tian R., and Abel E.D. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103 (2001) 2961-2966
47. Tian R., Nascimben L., Kaddurah-Daouk R., and Ingwall J.S. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J. Mol. Cell. Cardiol. 28 (1996) 755-765
48. Vakili B.A., Okin P.M., and Devereux R.B. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 141 (2001) 334-341
49. Villena J.A., Hock M.B., Chang W.Y., Barcas J.E., Giguère V., and Kralli A. Orphan nuclear receptor estrogen-related receptor α is essential for adaptive thermogenesis. Proc. Natl. Acad. Sci. USA 104 (2007) 1418-1423
50. Wallace D.C. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am. Heart J. 139 (2000) S70-S85
51. Weiss R.G., Chatham J.C., Charron M.J., Georgakopolous D., Wallimann T., Kay L., Walzel B., Wang Y., Kass D.A., Gerstenblith G., et al. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB J. 16 (2002) 613-615
52. Weiss R.G., Gerstenblith G., and Bootomley P.A. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc. Natl. Acad. Sci. USA 102 (2005) 808-813
53. Wende A.R., Huss J.M., Schaeffer P.J., Giguère V., and Kelly D.P. PGC-1α coactivates PDK4 gene expression via the orphan nuclear receptor ERRα: A mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol. 25 (2005) 10684-10694
54. Ye Y., Wang C., Zhang J., Cho Y.K., Gong G., Murakami Y., and Bache R.J. Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) 376-386